ABL is an invested partner in our clients' success, in bringing life-changing innovations to market. • Through GMP manufacturing, immunology and biomarker detection services—we accelerate vaccines, gene therapies, oncolytics and immunotherapies from bench to clinic, and market. • Learn more: https://ablinc.com/
Case study: We successfully advanced one vaccine technology company from research-based to Phase 1 clinical trials through developing and optimizing their platform, and enabling it to accommodate multiple indications.
ABL served as a catalyst in advancing one small biotechnology startup into a leading clinical-stage company that produces AAV viral vectors for innovative gene therapies for hereditary diseases. • We optimized their small-scale, laboratory process, was able to scale their production and purification processes, and evolved their product through R&D process development to GMP and large-scale 50 x 36-layer HYPERStacks.
Did you know: in addition to ABL's GMP manufacturing and immunology services we also offer research products—viral products, ELISA kits and antibodies and antiserum. • Take a look at our catalog here: https://ablinc.com/shop/
ABL maximizes precision and data quality while minimizing sample consumption. • Our ability to conserve small samples helps protect each critical time point of your product development pathway. • Learn more: http://ow.ly/zZZj50APeqT
We offer more sensitive biomarker detection for more analytes than other CROs. • 📈: The graph shows the relative sensitivities of each of those instruments pictured (Y-axis) versus the breadth of the number of analytes that can be assessed in the assay (X-axis).
Our scientists take on ownership of your work as if it were our own and are dedicated to its successful execution. • Let's start the discussion today: https://ablinc.com/
As a global leader in biomanufacturing and contract research we specialize in viral vector manufacturing and immunological research for product candidates in the following indications: cancer, neurological diseases, infectious and inflammatory diseases, auto-immune diseases and genetic and chronic diseases. • Learn more: https://ablinc.com/
We collaborate regularly with clients to uncover new methods to achieve efficiency. • We were able to creatively solve a challenge in viral expansion for a large biopharmaceutical customer. • Our scientists were able to work with extremely sensitive stock to successfully generate significant increases in viral volume production for preclinical studies. • What can we do for you? http://ow.ly/4z3V50ANPDX
We work hard to analyze our customers' innovations; we identify and mitigate gaps in product development plans and generate tailored processes for them. • For one company, we identified issues with their scouting material (i.e., a deficient viral product from a prior CMO). • Through optimization studies, we worked to generate seed virus from DNA constructs to create a new virus seed supporting their Phase 2 material. • Learn more about our GMP manufacturing capabilities here: http://ow.ly/JCis50ANPaU
